NYSE:SOLV

76.62
0.28 (0.37%) 1d
0
Investor Insights

This summary was created by AI, based on 1 opinions in the last 12 months.

Solventum Corp (SOLV-N) has recently faced scrutiny due to a significant shift in its dividend policy. An expert mentioned that a client sold their shares not out of negativity towards the stock but due to this dividend cut following a corporate spin-off. However, on a more positive note, recent earnings reports from Solventum indicate that the company is performing decently in terms of profitability, and its valuation appears reasonable in the current market context. This suggests that while there may be short-term concerns related to income-focused investors, the underlying fundamentals could indicate long-term potential. Overall, the company might be experiencing transitional challenges but is not necessarily considered a poor investment based on its recent performance.

Consensus
Mixed
Valuation
Fair Value
Similar
Fermium,FRM
COMMENT

She sold it, not because she's negative the stock, but this company spun off and dropped its dividend, and she was holding SOLV for clients in a dividend fund. Their recent reports have actually been good with decent earnings and a decent valuation.

PARTIAL BUY

3m completed spinning off healthcare company Solventum today. MMM shares have been challenged by many lawsuits, including over its hearing aids, and some of its businesses have slowed. An exception is Solventum, positing positive organic growth over the past decade. Revenues were $8.2 billion in 2023, but guidance said that 2024 will be a rebuilding year. That said, it's now selling at 11x this year's earnings, cheap. Keep in mind that most spun-offs start off shaky, with those getting initial shares not wanting them. So, buy Solventum gradually over the next 6 months. As for 3M, they paid dearly to settle their lawsuits, so the worst is behind them. Also, they're cutting costs like crazy. Also, Wall Street likes the change in CEOs.

Showing 1 to 2 of 2 entries
  • «
  • 1
  • »

Solventum Corp(SOLV-N) Rating

Ranking : 4 out of 5

Bullish - Buy Signals / Votes : 1

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 1

Stockchase rating for Solventum Corp is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Solventum Corp(SOLV-N) Frequently Asked Questions

What is Solventum Corp stock symbol?

Solventum Corp is a American stock, trading under the symbol SOLV-N on the New York Stock Exchange (SOLV). It is usually referred to as NYSE:SOLV or SOLV-N

Is Solventum Corp a buy or a sell?

In the last year, 1 stock analyst published opinions about SOLV-N. 1 analyst recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Solventum Corp.

Is Solventum Corp a good investment or a top pick?

Solventum Corp was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Solventum Corp.

Why is Solventum Corp stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Solventum Corp worth watching?

In the last year, there was no coverage of Solventum Corp published on Stockchase.

What is Solventum Corp stock price?

On 2025-04-02, Solventum Corp (SOLV-N) stock closed at a price of $76.62.